Cargando…

A STUDY OF PROPHYLACTIC VALUE OF ANTIPARKINSONIAN DRUG

The present prospective study is conducted to determine the prophylactic value of antiparkinsonian drug (A.P.) at the time of initiation of antipsychotic therapy. Seventy patients were selected who fulfilled the selection criteria. Thirty five patients received antipsychotic drugs alone (Group A), w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behere, P.B., Ramakrishna, P.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 1983
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012319/ https://www.ncbi.nlm.nih.gov/pubmed/21847288

Ejemplares similares

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
por: Silva, Sara, et al.
Publicado: (2021)

Antipsychotics dosage and antiparkinsonian prescriptions
por: Acquaviva, Eric, et al.
Publicado: (2007)

Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson’s Disease
por: SAMURA, Kazuhiro, et al.
Publicado: (2019)

Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis
por: Nimmons, Danielle, et al.
Publicado: (2021)

Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease
por: Taguchi, Soutarou, et al.
Publicado: (2021)

Rapid preparation process of antiparkinsonian drug Mucuna pruriens silver nanoparticle by bioreduction and their characterization
por: Arulkumar, Subramanian, et al.
Publicado: (2010)

Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2011)

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
por: Miguelez, Cristina, et al.
Publicado: (2017)

Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
por: Massari, Caio M., et al.
Publicado: (2017)

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
por: Paccione, Nicola, et al.
Publicado: (2022)

Time until modification of antiparkinsonian therapy in a group of patients from Colombia
por: Valencia-Vásquez, Aníbal, et al.
Publicado: (2023)

The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate
por: Lieu, Christopher A., et al.
Publicado: (2012)

Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
por: Pitcher, T. L., et al.
Publicado: (2014)

Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication
por: Chung, Jae Woo, et al.
Publicado: (2017)

Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets
por: Michel, Anne, et al.
Publicado: (2017)

LUHMES Cells: Phenotype Refinement and Development of an MPP(+)-Based Test System for Screening Antiparkinsonian Drugs
por: Beliakov, Sergei V., et al.
Publicado: (2023)

CHANGING DIAGNOSIS IN PSYCHIATRY
por: Behere, P.B., et al.
Publicado: (1988)

Antiparkinsonian medication masks motor signal progression in de novo patients()
por: Brzezicki, Maksymilian A., et al.
Publicado: (2023)

Motor Improvement-Related Regional Cerebral Blood Flow Changes in Parkinson's Disease in Response to Antiparkinsonian Drugs
por: Taguchi, Soutarou, et al.
Publicado: (2019)

The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database
por: Johannes, Catherine B., et al.
Publicado: (2022)

DHAT SYNDROME: THE PHENOMENOLOGY OF A CULTURE BOUND SEX NEUROSIS OF THE ORIENT
por: Behere, P.B., et al.
Publicado: (1984)

EFFECT OF LITHIUM THERAPY ON THYROID FUNCTION: A RETROSPECTIVE STUDY ON INDIAN PATIENTS
por: Srivastava, A.S., et al.
Publicado: (1993)

A STUDY OF CEREBRAL DOMINANCE BY LATERALITY SCORE AND ORDER OF REPORTING IN DICHOTIC LISTENING TEST
por: Shukla, Veena, et al.
Publicado: (1989)

1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
por: Ortíz de Zárate, Ana, et al.
Publicado: (2021)

EFFECT OF SEIZURE CONTROL ON IMPROVEMENT OF COGNITIVE FUNCTIONS IN EPILEPTIC PATIENTS
por: Nainian, M.R., et al.
Publicado: (1993)

c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism
por: Zhou, Yu, et al.
Publicado: (2018)

Stability of Psychiatric Diagnosis
por: Behere, P.B., et al.
Publicado: (1985)

Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model
por: Haghdoost-Yazdi, Hashem, et al.
Publicado: (2017)

Cannabis: Does it have a medicinal value?
por: Behere, Aniruddh P., et al.
Publicado: (2017)

A New Stereoselective Approach to the Substitution of Allyl Hydroxy Group in para-Mentha-1,2-diol in the Search for New Antiparkinsonian Agents
por: Podturkina, Alexandra V., et al.
Publicado: (2023)

Invisible scars of childhood adversity resurfacing as depression in later life
por: Chowdhury, Debolina, et al.
Publicado: (2022)

The 5-HT(2A) Receptor Antagonist M100907 Produces Antiparkinsonian Effects and Decreases Striatal Glutamate
por: Ansah, Twum A., et al.
Publicado: (2011)

The Value of Prophylactic Treatment in Anthrax
por: Faust, John
Publicado: (1894)

Coumarin analogue 3-methyl-7H-furo[3,2-g]chromen-7-one as a possible antiparkinsonian agent
por: Olaya, María del Pilar, et al.
Publicado: (2019)

THE CONCEPT OF AGING IN AYURVEDA
por: Dwivedi, K. K., et al.
Publicado: (1993)

Remarks on the Value of Quinine as a Prophylactic
por: Hamilton, J. Butler
Publicado: (1871)

A Comparative Study of Stress Among Students of Medicine, Engineering, and Nursing
por: Behere, Shashank P., et al.
Publicado: (2011)

The Prophylactic Value of Gymnastics of the Jaw
por: Kleinsorgen,
Publicado: (1914)

The Prophylactic Value of Gymnastics of the Jaw
por: Kleinsorgen,
Publicado: (1914)

The Prophylactic Value of Protective Injections
Publicado: (1919)

Cannot write session to /tmp/vufind_sessions/sess_qgen5ni854u1fq0rsbgj888ps6